What do technology, AI and the Arts have in common? In part 2 of an interview with Susan Magsamen, founder and director of the International Arts and Mind Lab Center for Applied Neuroaesthetics at Johns Hopkins University School of Medicine, Ms. Magsamen talks with BrainStorm host Meryl Comer about how technology and AI are best used to advance the evolving science of neuroaesthetics. Neuroaesthetics is an expanding field of research aimed at the intersection of psychological aesthetics, biological mechanisms, and human evolution. Ms. Magsamen is also co-author of the New York Times Bestseller, Your Brain on Art, How the Arts Transform Us. 

Produced by Susan Quirk and Amber Roniger.

Support the Show.

Art for Art's sake is about to become passe with the emerging science of neuroaesthetics, an expanding field of research aimed at the intersection of psychological aesthetics, biological mechanisms, and human evolution. Susan Magsamen, founder and director of the International Arts and Mind Lab Center for Applied Neuroaesthetics at Johns Hopkins University School of Medicine talks with BrainStorm host Meryl Comer about the health and healing benefits when we participate in the arts. Ms. Magsamen is also co-author of the New York Times Bestseller, Your Brain on Art, How the Arts Transform Us. 

Produced by Susan Quirk and Amber Roniger. 

Support the Show.

Alzheimer’s disease spares no one… and this story could easily be anyone’s story. Debra Tann Ed D., author of The Race of Dementia talks with host Meryl Comer about juggling her advocacy work while caring for her husband with dementia at home. Recipient of the 2023 Bright Focus Foundation Community Impact Award, Dr. Tann breaks the silence of the Alzheimer’s journey and talks about the stigma of Alzheimer’s and her push for education, equity, and access to health services for all. 

This episode is sponsored by Eisai.

Produced by Susan Quirk and Amber Roniger

Support the Show.

 Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke with host Meryl Comer about the ramification to patients and how this decision will create greater disparities. Take a listen.

This episode is sponsored by Genentech and Eisai. 

Support the Show.

We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine

In Part 2 of the interview with Amy Dockser Marcus, Pulitzer Prize winning Wall Street Reporter and Author, she and host Meryl Comer discuss a rare disease often likened to Children’s Alzheimer’s.  The common thread is advancing the science with new pathways for treating disease and conducting research. Amy talks about if this new collaborative research model aimed at saving children would work for elderly populations with long-term chronic diseases like Alzheimer’s. In the process to accelerate new drug development, science may be forever changed. 

This episode is sponsored by Genentech and Eisai.

If you have recommendations for topics or guests, email us at [email protected]. To learn more go to: https://www.usagainstalzheimers.org/

Support the show

We the Scientists: How a Daring Team of Parents and Doctors Forged A New Path for Medicine

 Pulitzer Prize winning Wall Street Reporter Amy Marcus, in her new book We the Scientists, discusses a rare disease often likened to Children’s Alzheimer’s with BrainStorm host, Meryl Comer. Not only are the patients young, but their parents are desperate to help scientists find a drug to slow disease progression to extend their lives. Most children, born seemingly normal, rarely live beyond the age of 20. The common thread is advancing the science with new pathways for treating disease and conducting research. In the process to accelerate new drug development, science may be forever changed.

This episode of BrainStorm is sponsored by Genentech and Eisai.

For more information about this episode and a search to cure Alzheimer's go to UsAgainstAlzheimers.org

Want to improve your brain’s performance? Find out the latest from Dr. Sandra Bond Chapman, Founder and Chief Director of The Center for BrainHealth at the University of Texas at Dallas. In this episode Dr. Chapman talks about progress on the world’s largest brain health study to measure improvements after training the brain.  No matter what your age, learn to maximize your cognitive potential to be as sharp as you were in your 30s and 40s.

This episode of BrainStorm is sponsored by Genentech and Eisai.

For more information about this episode and a search to cure Alzheimer's go to UsAgainstAlzheimers.org

Want to improve your brain’s performance? Why not? You’re using it anyway. Find out the latest from Dr. Sandi Bond Chapman, Founder and Chief Director of The Center for BrainHealth at the University of Texas at Dallas. In this episode Dr. Chapman talks about how to maximize your cognitive potential with the goal, no matter what your age, to be as sharp as you were in your 30s and 40s. To learn more about BrainStorm go to usagainstalzheimers.org.

This Episode of BrainStorm is sponsored by Genentech.